IP Library Granted Patent US 10,052,121
Granted Patent B2
US 10,052,121 · App. 15/654,779 · Granted Aug 21, 2018

Method for ablating body tissue

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,052,121
App. No.
15/654,779
Granted
Aug 21, 2018
Kind
B2
Abstract

A cardiac ablation method including the following steps: inserting a treatment catheter into an atrium of a heart, the treatment catheter including an ultrasound emitter; positioning the ultrasound emitter to face heart tissue within the left atrium outside of a pulmonary vein; emitting ultrasound energy from the ultrasound emitter while rotating the ultrasound emitter about a rotation axis; and ablating heart tissue with the ultrasound energy to form a lesion outside of a pulmonary vein.

Claims (28)

1. A method for creating a lesion in cardiac tissue, the method comprising:

positioning at a first location within a heart of a patient, an ultrasound transducer coupled to a distal portion of a catheter;

sweeping the ultrasound transducer along a first ablation path;

sensing a distance between the ultrasound transducer and the cardiac tissue,

wherein sensing occurs while the ultrasound transducer is sweeping along the first ablation path, and

wherein sensing generates an indicator signal;

checking the indicator signal to ensure that the first ablation path will result in a continuous transmural lesion; and

ablating the cardiac tissue with a beam of energy from the ultrasound transducer along the first ablation path to form the lesion,

wherein the ablation depth is dynamically controlled by varying a sweep rate of the ultrasound transducer along the first ablation path during ablation.

2. The method of claim 1 , wherein the lesion is formed without contact between the ultrasound transducer and the target tissue.

3. The method of claim 1 , wherein the same ultrasound transducer performs the sensing and the ablating.

4. The method of claim 1 , wherein sweeping the transducer comprises one or more of bending and rotating the catheter.

5. The method of claim 1 , further comprising moving the catheter to a second location with the heart, sweeping the transducer along a second ablation path, and ablating the cardiac tissue along the second ablation path.

6. The method of claim 5 , wherein moving the catheter comprises one or more of inserting, retracting, bending, or rotating the catheter.

7. The method of claim 5 , wherein moving the catheter comprises moving the catheter with a console and a control system coupled to the catheter.

8. The method of claim 5 , wherein moving the catheter comprises one or more of moving the catheter manually and moving the catheter with a microprocessor-controlled system.

9. The method of claim 1 , wherein sensing comprises operating the ultrasound transducer in a diagnostic mode and wherein ablating comprises operating the ultrasound transducer in an ablation mode.

10. The method of claim 9 , further comprising converting regularly from ablation mode to diagnostic mode and from diagnostic mode to ablation mode in order to generate an updated indicator signal while ablating the cardiac tissue along the first ablation path.

11. The method of claim 10 , further comprising adjusting the sweep rate along the first ablation path based on the updated indicator signal.

12. The method of claim 1 , wherein sweeping the ultrasound transducer along the first ablation path comprises sweeping the ultrasound transducer at the sweep rate, wherein the sweep rate is configured to allow sufficient time for the lesion to develop during ablation.

13. The method of claim 1 , wherein sensing comprises sensing at least a portion of an ultrasound beam generated by the ultrasound transducer and reflected back toward the ultrasound transducer by the cardiac tissue.

14. The method of claim 1 , wherein the amplitude of the reflected ultrasound beam depends on the acoustic properties of the cardiac tissue.

15. The method of claim 1 wherein sensing further comprises one or more of determining a residual tissue depth which has not been ablated or the depth of the lesion.

16. The method of claim 15 , further comprising halting ablation if the depth of the lesion the thickness of the cardiac tissue.

17. The method of claim 1 , further comprising adjusting a convergence of the beam of energy so as to compensate for an attenuation of the cardiac tissue.

18. The method of claim 1 , further comprising adjusting the distance between the ultrasound transducer and the cardiac tissue based on the indicator signal such that ablating the cardiac tissue along the first ablation path forms a continuous transmural lesion.

19. The method of claim 1 , further comprising bending the distal portion of the catheter, wherein the catheter comprises at least one pull wire and wherein bending the distal portion of the catheter comprises actuating the at least one pull wire.

20. The method of claim 1 , wherein the indicator signal comprises a color-coded display.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 9, 2020
From: VYTRONUS, INC.
To: AURIS HEALTH, INC.
Reel/Frame 052878/0555 →
CORRECTIVE ASSIGNMENT TO CORRECT THE ASSIGNEE NAME PREVIOUSLY RECORDED AT REEL: 043548 FRAME: 0076. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT . Recorded May 8, 2018
From: THAPLIYAL, HIRA V.; GALLUP, DAVID A.; ARENSON, JAMES W.
To: VYTRONUS, INC.
Reel/Frame 046093/0828 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 11, 2017
From: THAPLIYAL, HIRA V.; GALLUP, DAVID A.; ARENSON, JAMES W.
To: VYTRONUS, INC
Reel/Frame 043548/0076 →